Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension

Puis, Luc; Vandezande, Eddy; Vercaemst, Leen; Janssens, Patrick; Taverniers, Yvan; Foulon, Mark; Demeyere, Roland; Delcroix, Marion; Daenen, Willem
March 2005
Perfusion;Mar2005, Vol. 20 Issue 2, p101
Academic Journal
Introduction. Pulmonary thromboendarterectomy (PTE) is a surgical procedure which is considered the only effective and potentially curative treatment for chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a rare outcome from pulmonary emboli and, when left untreated, will result in right ventricular failure and death. Methods. From June 1999 to November 2003, 40 of these procedures were performed in our institution. Emphasis is placed on multidisciplinarity and cooperation between different medical and surgical disciplines. Perfusion management consists of myocardial and cerebral protection, deep hypothermia with multiple periods of circulatory arrest, reperfusion at hypothermia, hemofiltration and cellsaving techniques. Results. Hemodynamic improvement occurs immediately post operation. Mean pulmonary artery pressure decreased from 50±11 to 38±10 mmHg, pulmonary vascular resistance from 1246±482 to 515±294 dynes s/cm5 and cardiac index increased from 1.54±0.54 to 2.63±0.75 L/min per m2. Pump runs had an average duration of 187±29 min, circulatory arrest time was 29±11 min and crossclamp time 36±14 min. Extracorporeal membrane oxygenation can be an ultimate treatment for specific postoperative problems like persistent pulmonary hypertension and/or reperfusion pulmonary edema.


Related Articles

  • Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension. Iwase, T.; Nagaya, N.; Ando, M.; Satoh, T.; Sakamaki, F.; Kyotani, S.; Takaki, H.; Goto, Y.; Ohkita, Y.; Uematsu, M.; Nakanishi, N.; Miyatake, K. // Heart;Aug2001, Vol. 86 Issue 2, p188 

    Objective To assess acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Design-Cardiopulmonary exercise testing was performed in 20 patients with CTEPH before...

  • Foreword.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 1, pIV 

    A foreword to the "Current Medical Literature: Pulmonary Hypertension" is presented.

  • Empowered Patient Online Toolkit.  // Advances in Pulmonary Hypertension;Summer2012, Vol. 11 Issue 2, p104 

    The article recommends the comprehensive Empowered Patient Toolkit for patients with pulmonary hypertension by Pulmonary Hypertension Association (PHA).

  • Survival in Patients with Primary Pulmonary Hypertension. D'Alonzo, Gilbert F.; Barst, Robyn J.; Ayres, Stephen M.; Bergofsky, Edward H.; Brundage, Bruce H.; Detre, Katherine M.; Fishman, Alfred P.; Goldring, Roberta M.; Groves, Berton M.; Kernis, Janet T.; Levy, Paul S.; Pietra, Giuseppe G.; Reid, Lynne M.; Reeves, John T.; Rich, Stuart; Vreim, Carol E.; Williams, George W.; Wu, Margaret // Annals of Internal Medicine;9/1/91, Vol. 115 Issue 5, p343 

    Presents information on a study that characterized mortality in persons diagnosed with primary pulmonary hypertension and investigated factors associated with survival. Research methods; Results and discussion on the study; Conclusions.

  • 56-Year-Old Man With Progressive Shortness of Breath. Bhatia, Sundeep; Alegria, Jorge R.; Kalra, Sanjay // Mayo Clinic Proceedings;Apr2003, Vol. 78 Issue 4, p491 

    Describes a case of chronic thromboembolic pulmonary hypertension in a 56-year-old man. Presence of progressive shortness of breath; Test used in defining the severity and extent of the patient's disease; Most important factor in considering pulmonary thromboendarterectomy as primary therapy.

  • The endothelin system in pulmonary hypertension. Michel, Rene P.; Langleben, David; Dupuis, Jocelyn // Canadian Journal of Physiology & Pharmacology;Jun2003, Vol. 81 Issue 6, p542 

    Pulmonary hypertension (PH) may result from numerous clinical entities affecting the pulmonary circulation primarily or secondarily. It is recognized that vascular endothelial dysfunction contributes to the development and perpetuation of PH by creating an imbalance between vasodilating and...

  • Inhaled epoprostenol therapy for pulmonary hypertension: Improves oxygenation index more consistently in neonates than in older children. Brown, Anna T.; Gillespie, Jennifer V.; Miquel-Verges, Franscesca; Holmes, Kathryn; Ravekes, William; Spevak, Philip; Brady, Ken; Blaine Easley, R.; Christopher Golden, W.; McNamara, LeAnn; Veltri, Michael A.; Lehmann, Christoph U.; McMillan, Kristen Nelson; Schwartz, Jamie M.; Romer, Lewis H. // Pulmonary Circulation;2012, Vol. 2 Issue 1, p61 

    The purpose of this study was to determine the efficacy of inhaled epoprostenol for treatment of acute pulmonary hypertension (PH) in pediatric patients and to formulate a plan for a prospective, randomized study of pulmonary vasodilator therapy in this population. Inhaled epoprostenol is an...

  • Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation Kasimir, Marie-Theres; Seebacher, Gernot; Jaksch, Peter; Winkler, Günther; Schmid, Katharina; Marta, Gabriel M.; Simon, Paul; Klepetko, Walter // European Journal of Cardio-Thoracic Surgery;Oct2004, Vol. 26 Issue 4, p776 

    Objective: Pulmonary hypertension eventually leads to severe distortion of the cardiac geometry with consequent impact on cardiac function. The purpose of this study was to prove reverse cardiac remodelling after isolated bilateral lung transplantation (LuTX) in patients with advanced primary...

  • No doctor is an island. Yuan, Jason X. -J.; Morrell, Nicholas W.; Harikrishnan, S.; Butrous, Ghazwan // Pulmonary Circulation;2011, Vol. 1 Issue 4, p435 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the global awareness of pulmonary vascular disease, the relationship of high altitudes with pulmonary circulation, and abstracts from the 2011 Grover Conference.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics